Generic drugs maker Vitruvias nets $11.5 mln
Auburn, Alabama-based Vitruvias Therapeutics Inc, a maker of generic drugs, has closed $11.5 million in financing. JW Asset Management LLC and Perceptive Advisors led the round.
8 January 2018•1 min read
Auburn, Alabama-based Vitruvias Therapeutics Inc, a maker of generic drugs, has closed $11.5 million in financing. JW Asset Management LLC and Perceptive Advisors led the round.
